Shirin Kalimuddin - Infectious Diseases

Author Information

Shirin Kalimuddin is a prominent researcher affiliated with the Department of Infectious Diseases at Singapore General Hospital, located at 20 College Road, Singapore. Her work is primarily centered around infectious diseases, with a strong focus on COVID-19, vaccine responses, and other related topics. Her contributions to the field have been significant, as evidenced by her extensive publication record and citation metrics.

Research Contributions

Shirin Kalimuddin has made substantial contributions to the understanding of COVID-19 and its immunological aspects. Her research in 2021 has focused on various topics, including the detection of anti-Spike antibodies, T cell responses in COVID-19 patients, and the kinetics of SARS-CoV-2 infections. She has also explored the systemic adverse events associated with mRNA vaccines and the virological characteristics of the Delta variant. Beyond COVID-19, she has investigated treatments for Klebsiella pneumoniae bacteraemia and the clinical nuances in managing dengue fever. Her diverse research portfolio underscores her expertise in infectious diseases and her commitment to advancing scientific knowledge in this critical area.

Aliases

Shirin Kalimuddin is known by several aliases in academic publications, including S Kalimuddin and S. Kalimuddin. These variations in her name may appear across different research papers and citations.

Publication and Citation Metrics

Metric	Value
Total Number of Papers	117
Citation Count	8733
H-index	31

Publications:

Sensitive detection of total anti-Spike antibodies and isotype switching in asymptomatic and symptomatic individuals with COVID-19

DOI: 10.1016/j.xcrm.2021.100193

Year: 2021

Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients

DOI: 10.1016/j.celrep.2021.108728

Year: 2021

Baseline Enrichment of T and NK Cell Genes Predispose to mRNA Vaccine-Associated Systemic Adverse Events that Can Be Alleviated by Altering the Route of Vaccination

DOI: 10.2139/ssrn.3985604

Year: 2021

Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine-breakthrough infections: a multi-center cohort study

DOI: 10.1101/2021.07.28.21261295

Year: 2021

Cefazolin versus ceftriaxone as definitive treatment for Klebsiella pneumoniae bacteraemia: a retrospective multicentre study in Singapore.

DOI: 10.1093/jac/dkab009

Year: 2021

An unusual case of dengue fever in aneurysmal subarachnoid haemorrhage: diagnosis and management nuances.

DOI: 10.1080/02688697.2021.1946674

Year: 2021

Signatures of mast cell activation are associated with severe COVID-19

DOI: 10.1101/2021.05.31.21255594

Year: 2021

Robust Virus-Specific Adaptive Immunity in COVID-19 Patients with SARS-CoV-2 Δ382 Variant Infection

DOI: 10.1007/s10875-021-01142-z

Year: 2021

Acute acalculous cholecystitis in dengue fever: a case series.

DOI: 10.11622/smedj.2021168

Year: 2021

Gut Ruminococcaceae Levels Correlate with Risk of Antibiotic-Associated Diarrhea

DOI: 10.2139/ssrn.3901790

Year: 2021

When Should One Seek Medical Attention for Fatigue?

What Does the Future Hold?

What Role Do Vaccines Play?

What are Vaccines?

What Are the Applications of Proteomics in Infectious Diseases?

What is the Importance of Partner Notification?

How does Dengvaxia work?

How Do Aedes Mosquitoes Transmit Diseases?

What is Hygiene?

How are Structural Proteins Studied?

Partnered Content Networks

Relevant Topics